Telum Therapeutics
PrivateLast Round
Series A
Jul 1, 2026
Total Funding Raised
$25.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Telum Therapeutics is a biotechnology company that develops antimicrobial therapies based on engineered phage lytic proteins to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Telum Therapeutics Comparables
Compare Telum Therapeutics with similar companies based on industry and business-model similarity.
Telum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2026 | ||||
| Seed | Jul 13, 2020 |
Key People
Founding team and executive leadership
Telum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series A |
| CDTI Innvierte | Series A, Seed |
| Inveready | Series A |
| Clave Capital | Series A, Seed |
| Center for Technological Development and Innovation | Series A |
| Invivo Partners | Series A, Seed |
| Sodena | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
$21M round led by AMR Action Fund.
- Jun 23, 2026
Monthly visitors increased 82% MoM.
Telum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Telum Therapeutics's valuation, stock price, and market status.
Is Telum Therapeutics a public or private company?
Telum Therapeutics is a private company.
What is the current stock price of Telum Therapeutics?
Telum Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Telum Therapeutics worth (valuation)?
Valuation information for Telum Therapeutics is not publicly available.
Can I buy Telum Therapeutics stock?
Telum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Telum Therapeutics's last funding round?
Telum Therapeutics's most recent funding round was Series A on July 1, 2026.
Who are the main investors in Telum Therapeutics?
Key investors in Telum Therapeutics include AMR Action Fund.
Will Telum Therapeutics IPO soon?
No public IPO plans have been announced for Telum Therapeutics.
How can I track Telum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Telum Therapeutics's secondary market activity and sign up for updates.